The fibronexus in reactive and tumoral myofibroblasts: further characterisation by electron microscopy by Eyden, Brian
Histol Histopathol (2001) 16: 57-70 
http://www.ehu.es/histol-histopathol 
The fibronexus in reactive and 
tumoral myofibroblasts: further 
characterisation by electron microscopy 
B. Eyden 
Department of Histopathology, Christie Hospital NHS Trust, Manchester, United Kingdom 
Summary. Forty two surgical specimens containing 
myofibroblasts were studied to clarify the criteria for 
identifying the fibronexus, an ultrastructural feature 
regarded as a marker for myofibroblastic differentiation. 
Granulation tissue, tumour stroma, fibro-proliferative 
lesions (nodular fasciitis, myofibromatosis, inflam- 
matory myofibroblastic tumour) and malignancies 
(myofibrosarcoma and fibrosarcoma) were studied. 
Comparable results were found throughout these 
specimens, although fibronexus junctions were better 
developed in reactive compared with tumoral 
myofibroblasts. By electron microscopy, myofibroblasts 
were identified by abundant rough endoplasmic 
reticulum, peripheral smooth-muscle myofilaments with 
foca1 densities, and fibronexus junctions. The latter were 
recognised as  the points of convergence on the 
myofibroblast surfaces of intracellular myofilaments and 
extracellular fibronectin fibrils. The fibronectin fibrils 
were often co-linear with myofilaments. Also,  
fibronectin fibrils were dark-staining, straight and rigid- 
looking, and had a longitudinal filamentous substructure. 
A striking feature was the tendency of fibronectin fibrils 
to project into the surrounding extracellular space, away 
from the myofibroblast surface: in these respects, they 
differed significantly from lamina ("basement 
membrane"). The  presence of fibronectin fibrils 
correlated positively with fibronectin immunostaining by 
light and electron microscopy. Laminin and collagen IV 
showed variable and weak staining in the intercellular 
spaces in a minority of cases and never strongly stained 
myofibroblast surfaces. The data emphasise that the 
fibronexus has a number of distinctive features  
permitting identification, and constitute a reference-point 
for pathologists wishing to use electron microscopy to 
refine light microscopy diagnoses of putative 
myofibroblastic lesions. The role of the fibronexus in the 
definition of the myofibroblast is discussed. 
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lntroduction 
The myofibroblast is a mesenchymal cell with a 
predominantly spindled morphology in histological and 
ultrathin sections, described initially in granulation 
tissue, and regarded as having a role in wound healing 
(Gabbiani et al., 1971; Majno et al., 1971). The cell was 
subsequently identified in reactive tumour stroma, in a 
variety of fibro-proliferative lesions such as nodular 
fasciitis, the fibromatoses and certain pseudo-tumours 
(Schürch et al., 1998), and as neoplastic elements in 
malignancies (Eyden et al., 1991, 1992; Eyden and 
Christensen, 1993; Smith et al., 1995; Taccagni et al., 
1997; Mentzel et al., 1998; Gocht et al., 1999). The 
myofibroblast was originally defined by electron 
microscopy: it was found to have prominent rough 
endoplasmic reticulum (rER), modestly developed 
peripheral myofilaments of smooth-muscle-type, and a 
surface material first described as basement mernbrane- 
like material. The subsequent demonstration of a 
filamentous substructure and fibronectin content 
indicated that this was a structure differing significantly 
from lamina ("basement membraneW1), and it has, 
therefore, been referred to as the fibronectin fibril 
1: Basement membrane is the classical light microscopy term for the 
proteinaceous interface between epithelium and endothelium on the one 
hand, and matrix on the other. Electron microscopy has shown that one 
of the principal constituents of this zone is a dense plate of protein 
called the basal lamina. The preference for most electron rnicroscopists, 
therefore, is to use basal lamina rather than basement membrane. The 
term basal lamina is particularly appropriate where a cell shows an 
unambiguous apical-basal polarity. A nearly identical structure 
completely encircles individual muscle cells, adipocytes and nerve- 
sheath cells: here there is no apical-basal polarity and the term basal - 
although often used - is, therefore, inappropriate. For this reason, 
external lamina is often used, but since both basal and external laminae 
are outside aie cell, the simple term lamina has been preferred (Eyden, 
1996) and is used here. 
The fibronexus 
(Eyden, 1993). Its other main characteristic is that, from 
its point of contact with the cell surface, it projects into 
the extracellular space, and has been regarded as a 
means of transmitting intracellular contractile force to 
matrix to achieve overall tissue contraction. The point of 
convergence on the cell  surface of intracellular 
myofilaments and the extracellular fibronectin fibril is 
known as the fibronexus or fibronexus junction: this - in 
the context of other features (rER and myofilaments by 
electron microscopy, and smooth-muscle actin by 
immunostaining) - has been argued as an important 
marker for defining myofibroblastic differentiation 
(Eyden et al., 1991,1992; Eyden and Christensen, 1993; 
Eyden, 1993, 1996; Smith et al., 1995; Taccagni et al., 
1997; Gocht et al., 1999). 
In contrast to the perceived usefulness of the 
fibronexus in these papers, some authors have found the 
myofibroblast difficult to define (Mentzel and Fletcher, 
1997; Mentzel et al., 1998) and the fibronexus difficult 
to identify (Mentzel et al., 1998; Fletcher, 1999). Given 
the varied experience in which some pathologists can 
and some can not identify the fibronexus, this paper has 
the objective of giving a detailed description of the 
fibronexus in reactive and tumoral myofibroblasts, which 
can act as a reference-point to help those working with 
soft-tissue lesions reach more precise, differentiation- 
based diagnoses. 
Materials and methods 
Clinical material 
The study consisted of 42 specimens, which were 
either surgical accessions of the Christie Hospital, 
Manchester, or referrals from nearby district general 
hospitals. Diagnostic and clinical data are given in table 
1. Fifteen cases were primary or metastatic squamous 
cell carcinomas, for which fresh tissue was available for 
electron microscopy and glutaraldehyde fixation. A 
further 10 carcinomas with varying diagnoses and 4 non- 
carcinoma malignancies were sampled opportunistically 
for myofibroblastic stroma during the course of 
ultrastructural examination for routine diagnostic 
purposes (these included two pseudo-angiosarcomatous 
variants of squamous carcinoma). Here, tissue for 
electron microscopy was retrieved from histological 
formalin. Three samples of human granulation tissue 
presenting clinically as scar tissue following surgery for 
neoplastic disease, and 1 0  tumours or tumour-like 
lesions were also studied, with tissue for electron 
microscopy again being retrieved from histological 
formalin. 
Light and electron microscopy 
Al1 specimens were fixed in phosphate-buffered 
histological formalin, embedded in paraffin wax and 
sectioned at 4 p m  for subsequent staining in 
haematoxylin-and-eosin (H&E) for morphology and for 
immunohistochemistry. For light microscope immuno- 
staining, the following antibodies were obtained from 
Europath (Vector Labs), UK: anti-fibronectin (mouse 
monoclonal, code MFIB, dilution 1:5); anti-collagen IV 
(rabbit polyclonal, code PCO, 1:50), and anti-laminin 
(rabbit polyclonal, code PLA, 1:25). They were used in a 
3-step biotin-streptavidin-horseradish peroxidase 
complex method. For electron microscopy, al1 specimens 
were processed and sectioned as already described 
(Eyden et al., 1998), and ultrathin sections were 
examined in a JEOL JEM-1220 electron microscope. For 
immuno-electronmicroscopy, formalin-fixed tissue 
without osmication was embedded in LRWhite 
hydrophilic resin (Agar Scientific, UK) polymerised at 
50 "C. Ultrathin sections were collected on nickel grids, 
and exposed first to a primary unlabelled antibody, then 
to a secondary 15nm gold labelled antibody (British 
Biocell, UK). 
Results 
Al1 myofibroblasts had a plump, spindle-cell  
appearance in H&E sections with cytoplasm lacking 
obvious myofibrillar striations (Fig. 1A). By electron 
microscopy, they were identified by the presence of 
abundant rER cisternae, modestly developed bundles of 
smooth-muscle myofilaments with foca1 densities, and 
fibronexus junctions. The latter were recognised as the 
points of convergence on the myofibroblast surfaces of 
intracellular myofilaments and extracellular fibronectin 
fibrils. 
Fibronexus junctions were observed on myo- 
fibroblasts from al1 samples of tumour stroma (Figs. 1, 
3) and granulation tissue (Fig. 2), although they showed 
variation in the degree of development from cell to cell 
and case to case. They were also seen in nodular fasciitis 
(212 cases) (Fig. 5A-C), myofibromatosis (212 cases) 
(Fig. 5D), and single cases of inflammatory myofibro- 
blastic tumour (Fig. 5E), post-operative spindle cell 
nodule and paratesticular benign pseudo-tumour. A 
single example of fibroma of tendon sheath showed 
structures which were suggestive of fibronectin fibrils 
but which were less well developed and therefore less 
convincing as components of a fibronexus than the other 
specimens. Fibronexus junctions were also observed in 3 
soft-tissue malignancies not hitherto documented (two 
-Y 
Fig. l. Myofibroblasts from tumour stroma (case 1). A. Light micrograph of H&E-stained section to show plump, spindled myofibroblasts in a 
collagenised matrix between islands of tumour. x 400. B. Myofibroblasts and myofibroblast processes showing abundant rER, smooth-muscle 
myofilaments (mainly peripheral) (arrow-heads), and fibronectin fibrils (small arrows). x 5,000. C. Fibronexus characterised by intracellular myofilaments 
(rnf) in contact with an area of cell membrane (arrow-heads), and fibronectin fibril (small arrow) arising from the same area, and projecting out into the 
extracellular matrix. x 16,000 
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myofibrosarcomas (Fig. 6A, B) and a fibrosarcoma (Fig. 
6C). 
Fibronexus junctions in reactive2 myofibroblasts 
In tumour stroma and granulation tissue, the 
fibronexus was identified by intracellular smooth-muscle 
myofilaments interacting at a localised area of the cell 
membrane, usually a submembranous plaque, with an 
2: myofibroblasts from tumour stroma and from granulation tissue will be 
referred to collectively as reactive myofibroblasts. 
Table 1. Diagnostic and clinical information on specimens containing myofibroblasts. 
CASE REACTIVE TUMOUR STROMA 
primary keratinising SCC', cervical skin, M2 85 y$ 
poorly differentiated SCC metastatic to supraclavicular lymph node, F2 41 yr 
well differentiated SCC metastatic to inguinal lymph node, F 85 yr 
keratinising SCC metastatic to cervical lymph node, F 65 yr 
poorly differentiated SCC metastatic to axillary node, F 35 yr 
primary well differentiated SCC, inguinal fibro-faiiy tissue, F 48 yr 
recurrent SCC, tongue, M 48 yr 
poorly differentiated SCC metastatic to inguinal lymph node, F 56 yr" 
extra-nodal deposit of moderately differentiated SCC (block neck dissection). M 52 yr 
primary invasive moderately differentiated SCC, neck, M 89 yr 
primary invasive, well differentiated SCC, nose, F 88 yr 
poorly differentiated SCC metastatic to cervical node, M 59 yr 
primary invasive moderately differentiated SCC, temple, M 66 yr 
well differentiated SCC, leg, F 83 yr 
primary moderately differentiated non-keratinising SCC, pinna, M 79 yr 
primary pseudo-angiosarcomatous SCC of pinna of ear, M 78 yr 
primary pseudo-angiosarcomatous SCC of breast, F 73 yr 
adenocarcinoma of unknown primary site metastatic to cervical lymph node, M 44 yr 
primary invasive poorly differentiated adenocarcinoma, colon, F 88 yr 
carcinoma with chondroid metaplasia of unknown primary site metastatic to small bowel. F 42 yr 
primary secretory carcinoma of breast, F 44 yr 
primary undifferentiated large-cell carcinoma, skin of neck. M 55 yr" 
primary pleomorphic lobular carcinoma, breast, F age not known 
primary ductal carcinoma, breast, F age not known 
primary ductal carcinoma, breast, F age not known 
primary malignant myoepithelioma, submandibular gland, F 57 yr 
primary desmoplastic malignant melanoma, naso-labial fold, F 79 yr 
extraskeletal myxoid chondrosarcoma, thigh, M 14 yr 
malignant fibrous histiocytoma, arm, M 65 yr 
CASE GRANULATION TISSUE 
30 granulation tissue, knee, M 39 yr 
3 1 granulation tissue, dermis (skin of calf), F 32 yr 
32 granulation tissue, nose, F 65 yr" 
CASE TUMOURSTTUMOUR-LIKE LESlONS 
nodular fasciitis, supra-pubic mass, F 66 yr 
nodular fasciitis, calf, M 30 yr 
musculo-aponeurotic fibromatosis, buttock, F 52 yr 
inflammatory myofibroblastic tumour/pseudo-tumour, larynx, M 60 yr 
post-operative spindle cell nodule, vulva, F age not known 
fibroma of tendon sheath, M age not known 
benign fibrous proliferation (fibrous pseudo-tumour), paratesticular mass, M 42 yr 
small intestinal myofibrosarcoma metastatic to liver, F 17 yr 
fibrosarcoma, biceps muscle, F 23 yr 
myofibrosarcoma, skin of ear, M 64 yr 
l :  SCC, squamous cell carcinoma; 2: M, male; F, female; 3: yr, years; 4: studied by immuno-electronmicroscopy. 
Fig. 2. Myofibroblasts from granulation tissue (case 31). A. Low-magnification view showing abundant rER (*). Fibronexus junctions are inconspicuous 
(arrows). x 10,000. B. Medium-power view of "basement-membrane-like material" (fibronectin fibril) (arrows). The material looks amorphous owing to 
orientation within the section. x 30,000.C. High-magnification view of the fibronexus showing the end of a cytoplasmic process containing actin 
myofilaments (m9 in a co-linear orientation (long arrows) with respect to the extracellular fibronectin fibril (short arrows) which has a clearly defined 
filamentous substructure. x 60.000 
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Flg. 3. Myofibroblasts from tumour stroma (A and C, case 1; B, case 3). A. Myofibroblast showing myofilaments (mf) and a fibronectin fibril (arrow), a 
pati of which has sheet-like or ribbon-like area (arrow-heads). The distance between the arrow-heads is about 600 nm. x 22,000. B. Myofibroblast with 
comparatively modestly developed rER, but well developed peripheral myofilaments (m9 and fibronectin fibrils (arrows). The more slender fibril 
(asterisked arrow) has a superficially lamina-like appearance. x 20,000. C. Myofibroblast surface adorned with a large number of fibronectin fibrils 
(arrows). x 7,500 
extracellular fibril, the fibronectin fibril. Generally at low 
magnifications, the fibronectin fibril was conspicuous 
and acted as a marker for the fibronexus. At low power 
particularly, fibronectin fibrils often appeared dense and 
somewhat irregularly organised (Fig. 1B). Very often, as 
revealed under higher magnification, they were 
associated with myofilaments in a co-linear fashion, i.e., 
the myofilaments and the fibronectin fibril had the same 
directional arrangement (Fig. 1C): this applied even to 
poorly developed fibronexus junctions (Fig. 2C). 
Typically, fibronectin fibrils were dark-staining, straight 
and rigid-looking, and had a longitudinal filamentous 
substmcture (Figs. lC, 3A). One of the most striking and 
characteristic features of the fibronectin fibril was its 
tendency to project out into the surrounding extracellular 
space, away from the myofibroblast surface (Figs. lC, 
3A). In this respect, the fibronectin fibril differed 
significantly from lamina, which normally follows the 
contour of the cell surface. On occasion, however, a 
lamina-like profile was seen (Fig. 3B). This was 
invariably restricted to a localised region of the cell 
surface and, given that many fibronectin fibrils appeared 
to have a broad ribbon-like profile (Fig. 3A), these 
lamina-like profiles (in the context of immuno- 
electronmicroscopy results - see below) were interpreted 
as being cross-sections of broad fibronectin ribbons. 
Appropriately sectioned myofibroblasts revealed large 
numbers of fibronectin fibrils at the cell surface (Fig. 
3C). 
Matrix protein staining in tumour stroma and granulation 
tissue 
Staining for fibronectin was observed in al1 cases 
(Fig. 4A), although staining intensity varied. Often 
myofibroblast surfaces and extracellular matrix some 
distance from myofibroblasts were emphasised in fibril- 
like patterns of staining. Laminin and collagen IV 
showed variable staining in the intercellular spaces in a 
minority of cases and myofibroblast surfaces were never 
strongly stained. 
Immuno-electronmicroscopy for fibronectin revealed 
highly specific staining for fibronectin fibrils (Fig. 4B) 
corresponding with the staining pattern by light 
microscopy (Fig. 4A). Staining with anti-collagen IV 
and anti-laminin antibodies gave sparse, widely 
dispersed and individual gold particles on the surfaces 
and over the cytoplasm of myofibroblasts (possibly 
representing a degree of non-specific staining) but 
consistently failed to show significant label on 
myofibroblast surfaces (Fig. 4C, D). 
Tumoral fibronexus junctions 
In nodular fasciitis, myofibromatosis, inflammatory 
myofibroblastic tumour (Fig. S), post-operative spindle- 
cell nodule, paratesticular benign pseudo-tumour, 
myofibrosarcoma and fibrosarcoma (Fig. 6), fibronexus 
junctions were identified with the same architecture as in 
the reactive myofibroblasts. The degree of development 
varied, however, with exuberant expression of 
myofilaments and fibronectin fibrils in some of the 
benign lesions, and generally, less well developed or 
imperfecty formed fibronexus junctions in the 
malignancies. However, even among the latter the 
distinctive features of the fibronexus were identifiable: 
m-linearity of myofilaments and fibronectin fibrils, the 
latter being straight, having a filamentous substructure 
and diverging away from the cell surface (Fig. 6A,B). In 
the fibrosarcoma, an imperfectly organised fibronexus 
was observed, lacking the myofilaments in the 
immediate vicinity of a shelf of cell surface (Fig. 6C). 
Dlscussion 
This paper presents both novel and confirmatory 
findings on the myofibroblast, and in particular, the cell- 
to-matrix specialisation known as the fibronexus. Most 
authorities recognise that myofibroblasts from tumour 
stroma and granulation tissue are characterised by 
prominent rough endoplasmic reticulum (rER) and 
modestly developed bundles of smooth-muscle 
myofilaments with foca1 densities, consistent with the 
matrix production and contractility characteristic of 
healing wounds (Majno et al., 1971), and with the 
retraction phenomenon commonly observed, for 
example, in carcinomas (Schürch et al., 1982). A number 
of authors have recognised an additional feature of the 
Flg. 4. Matrix protein imunostaining. A and B case 8 (tumour stroma); C and D case 32 (granulation tissue). A. LigM micrograph showing a line of 
fibronectin immunoreactiviiy (arrow) consistent with a fibronectin fibril. x 800. B. Immuno-electron microscopy oí gold-labelled anti-fibronectin antibody 
showing speciñc localisation wer a fibronectin fibril. x 13,000. C and D. Absence oí collagen IV staining over a myofibroblast. C shows a myofibroblast 
(My) close to an entrapped striated muscle cell (Mu) (the dense bodies lower left are obliquely sectioned sarcomeric fibrils). Collagen IV staining is 
observa over the musde cell lamina (arrows). x 6,000. D is a detail from C. The myofibroblast has prominent rER, and, despite imperfect structural 
prese~ation due to the lack of osmium tetroxide in the processing schedule, a small bundle of rnyofilaments as pati of a small fibronexus is evident 
(arrow). Note the absence of collagen 1V staining over the myofibroblast compara with the lamina of the adjacent muscle cell. x 25,000 
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Flg. 5. Fibronexus junctions in benign lesions. A-C. Nodular fasciitis (A and B, case 33; C, case 34). D. Musculo-aponeurotic fibromatosis, case 35. 
E. lnñammatory myoñbroblastic tumour, larynx, case 36. In al1 figures, densely staining and relatively straight fibronectin fibrils are shown (arrows), 
associated with smooth-muscle myofilaments (mf) with focal densities. Throughout, the myofilaments and the fibronectin fibril follow the same direction. 
Note also in B how the plasma membrane overlying the myofilaments is rufñed, suggesting contraction and a folding of "excess" membrane. A, x 8,000; 
B. x 13,000; C. x 20,000; D, x 18,000; E, x 15,000 
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myofibroblast, originally described as basement 
membrane-like material (Gabbiani et al., 1971) and more 
recently referred to as the fibronectin fibril (Eyden, 
1993), as an important ultrastructural feature for defining 
the myofibroblast and identifying myofibroblastic 
differentiation in tumours (Eyden et al., 1991, 1992; 
Eyden and Christensen, 1993; Eyden 1993; Smith et al., 
1995; Taccagni et al., 1997; Gocht et al., 1999). 
For others, however, the fibronexus is less important. 
One reason is that over the past 20 years electron 
microscopy as a diagnostic technique in general has lost 
ground in perceived importance to immunohisto- 
chemistry. Consequently, many use a-smooth-muscle 
actin immunostaining in an appropriate morphological 
and clinical setting for defining the myofibroblast 
(Darby et al., 1990; Nouchi et al., 1991; Foo et al., 1992; 
Ma et al., 1992; Pedagogos et al., 1997; Morgan and 
Pitha, 1998; Bisceglia and Magro, 1999). Another reason 
is the simple inability on the part of some service 
pathologists to recognise this cell structure (Mentzel et 
al., 1998; Fletcher, 1999). This might seem surprising 
given that, as indicated in table 2, there are at least 28 
publications in the literature containing informative 
illustrations of the fibronexus. Clearly, however, these 
papers have not made an appropriate impact on 
diagnostic pathologists in terms of providing data to 
allow them to make confident interpretations of the 
fibronexus. Possibly, this is due to the fact that many of 
these papers have appeared in the scientific or 
specialised clinical literature and not the "mainstream" 
diagnostic pathology journals which are the required 
reading for practising service pathologists. The data in 
effect are relatively inaccessible and also dispersed: the 
importance of the present paper is that it assembles a 
comprehensive range of images of the fibronexus for the 
purpose of providing a reference-point for pathologists 
who wish to refine their diagnoses based on 
differentiation characteristics. 
The main characteristics which these images 
illustrate are: the composite nature of the fibronexus 
(intracellular myofilaments and an extracellular fibril 
converging at a point or points on the cell surface, often 
marked by a submembranous plaque); co-linearity of 
myofilaments and fibronectin fibrii; a finely ñlamentous 
substructure, relatively dense staining, and an often 
straight and rigid-looicing profile to the fibronectin fibril; 
and finally, the divergence from the cell surface of the 
fibronectin fibril into the matrix (Fig. 7). In none of 
these characteristics does the fibronexus or fibronectin 
fibril resemble lamina ("basement membrane") (Reale, 
1984; Eyden, 1996). The latter is often a more lightly 
staining structure, but more importantly, it typically 
adheres faithfully to cell surface contours, and it has a 
relatively homogeneous substructure. These images 
should therefore help to identify the fibronexus junction 
Table 2. Publications illustrating the fibronexus/fibronectin fibrils. 
REFERENCE FIGURE TISSUELESION 
Bhawan et al., 1979 
Baur et al., 1978 
Baur and Parks, 1983 
Dominguez-Malagon, 1993 
Ehrlich et al., 1994 
Eyden et al., 1991 
Eyden et al., 1992 
Eyden, 1993 
Eyden, 1996 
Eyden and Christensen, 1992 
Flint and Poole, 1990 
Gocht et al., 1999 
Holstein et al., 1996 
lshizaki et al., 1994 
Kuhn and McDonald, 1991 
Upper et al., 1980 
Meek, 1994 
Ryan et al., 1974 
Santucci et al., 1989 
Schürch et al., 1998 
Seemayer et al., 1980 
Singer, 1989 
Singer et al., 1985 
Skalli and Gabbiani, 1988 
Smith et al., 1995 
Taccagni et al., 1997 
Tomasek et al., 1987 
Vracko and Thorning, 1991 
4 
19 
l l a  
2 
38 
3 
9 1  1 
1 
69A,B 
2-3 
10.1 
4C 
6 
1 OA 
34 
1 o 
435 
8 
12 
1 f 
20 
1 A 
2a 
4 
8 
6 
2,4,7,8 
58 
infantile digital fibroma 
scar contracture 
granulation tissue and 
immature scars 
granulation tissuel 
hypertrophic scar 
myofibrosarcoma 
myofibrosarcoma 
tumour stroma 
tumour stroma 
myofibrosarcoma 
Dupuytren's disease 
myofibrosarcoma 
seminiferous tubule2 
traumatised cornea3 
idiopathic pulmonary fibrosiss 
desmoid4 
malignant fibrous histiocytoma6 
granulation tissue 
multicystic peritoneal 
mesothelioma7 
granulation tissue 
tumour stroma 
in vitro fibroblasts 
granulation tissue 
rat endothelial cell6 
myofibrosarcoma 
myofibrosarcoma 
Dupuytren's disease 
myocardial scara 
l: also referred to as anchoring fiberslñlaments; 2: not well developed 
and not referred to as fibronexus; 3: shows a fibronectin fibril and uses 
the term fibronexis; 4: shows fibronectin fibril rather than entire 
fibronexus; 5: referred to as microtendon; 6: the specificity of the 
fibronexus is dealt with in a separate paper; 7: associated with 
"mesenchymal-like mesothelial cells'; 0: myofilaments referred to as 
nonsarcomeric myocytoskeletal arrangement. 
* 
Flg. 6. Fibronexus junctions in malignancies. A and B, rnyofibrosarcoma (case 40); C, fibrosarcoma (case 41). A. Spindled cell showing nuclear 
irregularity and disorganised rER cisternae, peripheral myofilaments (m9 and (arrow) a fibronexus junctimn. B. Detail showing the fibronectin fibril 
(arrow) projecting into the extracellular space, and co-linear (indicated by arrows) with a bundle of myofilaments (m9. C. Fibronectin fibril (arrow) 
contacting a sheH-like area of cell membrane at what can regarded as an incomplete fibronexus (*) given that myofilaments do not appear to be 
present. Another fibronectin fibril is overiying an area of cell surface at bottom right. A, x 12,000; B, x 30,000; C, x 20,000 
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and distinguish it from lamina. 
Not surprisingly, the fibronexus is best illustrated 
and best developed in granulation tissue and tumour 
stroma myofibroblasts, cells which can be regarded as 
close to normal in terms of their differentiation (in the 
sense of being non-neoplastic). Nonetheless, cells from 
fibro-proliferative lesions and pseudo-tumours also have 
well-defined fibronexus junctions which, as shown here, 
are readily identifiable. This paper shows for the first 
time the full complement of features of the fibronexus in 
nodular fasciitis and inflammatory myofibroblastic 
Fig. 7. Representation of the fibronexus. FNX: fibronexus; rnf: smooth- 
rnuscle myofilarnents; fd: focal density; prn: plasrnalernrna; p: sub- 
rnembranous plaque; ff: fibronectin fibril. 
tumour, hinted at in earlier papers. Well developed 
fibronectin fibrils but without the demonstration of co- 
linearity with myofilaments have been illustrated in 
nodular fasciitis (figure 6 in Wirman, 1976), while in 
plasma cell granuloma (inflammatory pseudo-tumour) a 
well defined fibronectin fibril was illustrated with an 
observable longitudinal filamentous substructure close to 
a bundle of myofilaments (figure 3 in Chou et al., 1988). 
In both instances, the term basement membrane-like 
material was used. Our observations also confirm the 
presence of fibronectin fibrils already illustrated in 
fibromatoses (Bhawan et al., 1979; Lipper et al., 1980). 
Preliminary immuno-ultrastructural results, 
demonstrating fibronectin but not laminin or collagen IV 
over the surfaces of myofibroblasts, are consistent with 
the idea that the fibonectin fibrils are distinct from 
lamina. Lamina-like profiles, however, can be seen on 
the surfaces of myofibroblasts (Fig. 3B) and lamina has 
sometimes been reported as a feature of myofibroblasts 
(Schürch et al., 1998). Given the immuno-ultrastructural 
lack of lamina proteins in this study, however, these 
lamina-like profiles may represent cross-sectional views 
of sheet-like fibronectin fibrils (Fig. 3A). This does not 
exclude the possibility that fibronectin fibrils and foci of 
true lamina co-exist on the myofibroblast surface, 
although at present the evidence for true lamina is 
tentative. Given the presence of lamina proteins in the 
matrix of some myofibroblast proliferations as shown 
here and elsewhere (Betz et al., 1992; Berndt et al., 
1994; Kosmehl et al., 1995; Magro et al., 1997), 
however, the protein composition of the myofibroblast 
surface and surrounding matrix deserves further 
investigation. 
In the cases of malignancies, one can expect a more 
pronounced loss of development of the fibronexus, but 
even in these tumours, unambiguous examples of the 
fibronexus have been published (Eyden et al., 1992; 
Smith et al., 1995; Taccagni et al., 1997; Gocht et al., 
1999), and further examples are provided here, where al1 
the features of the fibronexus as defined above in 
reactive myofibroblasts can be seen. Naturally again, in 
some instances, the fibronexus can be expected to be 
imperfectly assembled (as in the fibrosarcoma, Fig. 6C): 
in this respect the fibronexus is no different from other 
diagnostically important organelles such as 
melanosomes and desmosomes which can also show 
reduced or imperfect development (Eyden, 1996). 
Having characterised the fibronexus, it is appropriate 
to  comment on i ts  significance for  defining the 
myofibroblast. This is a complex subject in which 
widely different views have been expressed, ranging, on 
the other hand, from the use of light microscopy and 
especially a-smooth-muscle actin immunostaining 
(Darby et al., 1990; Nouchi et al., 1991; Foo et al., 1992; 
Ma et al., 1992; Pedagogos et al., 1997; Morgan and 
Pitha, 1998; Bisceglia and Magro, 1999) to, on the other, 
a combination of light microscopical and ultrastructural 
criteria including the fibronexus and other organelles 
(Eyden, 1993; Schürch et al., 1998, Lagacé et al., 1999). 
The fibronexus 
It is beyond the scope of this discussion to go into the 
detail required to deal adequately with this question, but 
the following brief points will be made. 
The fibronexus can be regarded as an important 
criterion for defining the myofibroblast or myofibro- 
blastic differentiation in tumour cells because it is a well 
developed and consistently observed feature of tumour 
stromal and granulation tissue myofibroblasts, cells 
which can reasonably be regarded a s  the nearest 
approach to the normal counterparts of a myofibroblastic 
tumour. It is, however, only one feature among a number 
which collectively define rnyofibroblastic differentiation, 
the others being rER, modestly developed smooth- 
muscle myofilaments and a-smooth-muscle actin 
immunostaining. Observing al1 of these features gives 
maximum confidence of identifying myofibroblastic 
differentiation in tumours. These features were useful in 
enabling us to identify a spindle-cell tumour positive for 
a-smooth-muscle actin and diagnosed as a leiomyo- 
sarcoma by light microscopy as a myofibrosarcoma 
(Eyden et al., 1992). Incidentally, desmin has also been 
observed in certain myofibroblastic lesions (Skalli et al., 
1989) and has sometimes been described in terms of a 
marker for myofibroblasts (van der Ven and Fürst, 1998). 
Given that desmin is also found in smooth muscle cells 
and leiomyosarcoma, it must be regarded as having 
limited value in the distinction, for example, of leiomyo- 
sarcoma and myofibrosaroma (Mentzel et al., 1998). 
The absence of fibronexuses in an appropriate 
context can suggest smooth-muscle rather than 
rnyofibroblastic differentiation, and an example with 
implications for understanding differentiation is  
myofibroblastoma. These are widely regarded as being 
rnyofibroblastic. In our hands, however, a number of 
myofibroblastomas were found to lack fibronexus 
junctions and possess instead the lamina and attachment 
plaques altemating with plasmalemmal caveolae (Eyden 
et al., 1996, 1999) characteristic of smooth-muscle cells 
(Faussone-Pelegrini et al., 1989; Motta, 1990). They 
were, therefore, interpreted as kinds of smooth-muscle 
tumour. This may be a further reason why the fibronexus 
has been regarded as difficult to identify - that it has 
been sought but not found in tumours expected to 
harbour them because of an erroneous belief that they 
are myofibroblastic. 
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